Larimar Therapeutics (LRMR) Total Debt (2014 - 2020)

Larimar Therapeutics (LRMR) has reported Total Debt for 7 consecutive years, with $14.0 million the latest figure, recorded in Q1 2020.

• For the quarter ending Q1 2020, Total Debt fell 32.59% year-over-year to $14.0 million; the trailing twelve-month figure through Mar 2020 stood at $14.0 million (down 32.59% YoY), and the FY2019 full-year result was $15.7 million, down 23.75% from the prior year.
• Total Debt eased to $14.0 million in Q1 2020 per LRMR's latest filing, from $15.7 million in the prior quarter.
• Across five years, Total Debt topped out at $24.1 million in Q3 2018 and bottomed at $1.3 million in Q3 2017.
• Historically, Total Debt has averaged $12.9 million across 5 years, with a median of $15.7 million in 2019.
• The sharpest annual moves came in 2017 and 2018: Total Debt slumped 70.64% in 2017, then soared 1803.47% in 2018.
• Over 5 years, Total Debt stood at $3.6 million in 2016, then surged by 457.26% to $20.0 million in 2017, then rose by 3.2% to $20.6 million in 2018, then decreased by 23.75% to $15.7 million in 2019, then dropped by 10.91% to $14.0 million in 2020.
• According to Business Quant data, Total Debt over the past three periods registered $14.0 million, $15.7 million, and $17.4 million for Q1 2020, Q4 2019, and Q3 2019 respectively.